Two paths from today. The gap between them widens every year.
Year 1 has already begun. As of March 2026: £32.9M of DPIF revenue and £13.1M of capital remain unallocated; the Accountable Officer has formally stated delivery is “not possible without confirmed DPIF allocation”; recruitment is frozen by remit letter; the CFO and the sharpest non-executive director (Rowan Gardner) have departed; two of forty-seven Phase One milestones have already been missed (LIMS and WRISTS); the IQPD oversight meetings are being wound down and replaced by a new escalation meeting chaired by the Director General from April. The figures below are not hypothetical at year zero — they are the trajectory if the conditions documented at March 2026 continue.
DHCW’s annual budget reached approximately £200M in 2025-26 — a year-on-year growth trajectory that has accelerated since founding. Quantified delivered value across the full five years remains £0.5M — the Finance Director’s own admission. Against a £200M annual budget producing no measurable patient or clinician benefit at scale, the direct waste rate is £100-150M per year, not the conservative £25-40M figure used in earlier estimates. The conservative figure was anchored on a single waste category — re-procurement savings — and was always understood to be a floor, not a central estimate.
£5-15M one-off investment in review, recruitment, handover, and temporary capability gaps.
Against the current annual waste rate of £100-150M — 50-75% of the £200M DHCW annual budget producing no quantified delivered value — the transition investment breaks even within weeks, not months.
Cumulative direct DHCW waste avoided over five years: £500M-£1B.
Downstream savings across the seven health boards and NHS Wales are 5-15× this direct figure — clinician time recovered, patient-safety incidents prevented, cross-border referrals reduced, delivery delays removed. Five-year total NHS Wales impact: £3-10 billion.
Year 1: £100-150M direct DHCW waste. Level 4 Targeted Intervention deepens.
Year 2: Technical attrition 15-20%. Major programme enters crisis. Cumulative direct: £200-300M.
Year 3: Vendor dependencies deepen. Patient-safety incidents increase. Cumulative direct: £300-450M.
Year 4: Programmes in discovery remain in discovery. Shadow IT proliferates. Cumulative direct: £400-600M.
Year 5: Crisis-forcing event likely. Reform costs 2-3×. Cumulative direct: £500M-£1B (with crisis premium).
Direct DHCW waste only. Downstream impact across the seven health boards and NHS Wales is 5-15× these figures — total five-year cost £3-10 billion. Patient harm is not on this ledger.
The Figures Above Are The Floor, Not The Ceiling
The fork above quantifies direct DHCW waste — Welsh Government funding consumed without corresponding delivered value. These figures are already substantial. They are not the whole cost.
Every DHCW failure cascades outward. Seven health boards and three trusts depend on DHCW for national clinical systems, referral infrastructure, patient records, and interoperability. When WPAS malfunctions, the cost is not borne by DHCW — it is borne by clinicians whose lists break, by patients whose appointments are lost, and by the Welsh NHS budget that absorbs the delays. When WCCIS fails to deploy, community care teams build shadow IT and duplicate work. When cross-border referrals spike because Welsh digital infrastructure cannot cope, NHS Wales pays English providers to take Welsh patients — over 30,000 currently waiting across the border.
The PSBA outage of March 2026 makes the multiplier visible in a single event. When the Public Sector Broadband Aggregation network failed across all NHS Wales organisations, every health board lost O365, EPMA, RISP, and radiology simultaneously. Clinical lists could not be opened. E-prescribing stopped. Image viewing stopped. The cost of that single day was not borne by DHCW — DHCW does not own PSBA — but it was a direct consequence of architectural decisions about single-supplier shared dependencies that the diagnosis documents at L5: The Vendor Dependency Spiral. Multiply that day by every clinical hour lost across every health board: this is the downstream multiplier in concrete form.
The downstream multiplier is difficult to quantify precisely because the captured governance has not published the data to quantify it (see L10: The Information Fortress). But directionally: for every £1 of direct DHCW waste, the downstream cost to health boards and NHS Wales is plausibly £5-15 — clinician hours consumed, patient-safety incidents, duplicated procurement, delayed treatment, cross-border referral costs. The March 2026 PSBA outage demonstrated the multiplier in a single event: a few hours of failure at the supplier level produced a full operational day’s worth of lost capacity across every health board simultaneously. The system-dynamics term is externality: DHCW’s dysfunction is a cost exported to everyone else in the Welsh NHS.
This is why the diagnosis is not a DHCW-internal matter. It is an NHS Wales matter.
Total Five-Year Impact Across NHS Wales: £3-10 Billion
Doing the arithmetic at the current run-rate: £500M-£1B of direct DHCW waste over five years, multiplied by a 5-15× downstream factor, implies total cost to NHS Wales of £3-10 billion over the five-year window. These are the numbers the Welsh NHS is currently paying, in clinician time, in patient-safety incidents, in cross-border referrals, and in delivery delays, for a delivery body that produces 83p of delivered value per £1,000 invested.
This is the scale. It is not rhetoric. It is straightforward compounding of the direct rate, the downstream multiplier, and the five-year window over which the reform sequence unfolds.
The Cost That Is Not Counted
The figures above are pounds. They do not include the cost of harm to patients, because that cost is not on the same scale as money. WPAS has been linked to at least one patient death. The electronic master patient index has mixed up patient records. WCCG ran on unsupported technology for more than eight years against repeated technical-staff warnings. WICIS — the intensive care system — has been “effectively still on pause,” with Welsh Government commissioning an independent patient safety review. The Royal Colleges’ joint briefing of July 2025 found that patients “regularly experience delays that lead to worsening health.”
Each of these is a category of harm that has no exchange rate to pounds. The £3-10 billion five-year figure is what NHS Wales is paying in money. What patients are paying is a separate ledger, and the entries on it cannot be undone by future reform — they have already accrued. The case for planned reform is not only economic. The case is that every additional month of the status quo adds entries to a ledger that should never have been opened.
The question is not whether reform happens. The question is whether Wales chooses planned reform now, at £5-15M, or crisis-forced reform later at two to three times that direct cost — with the downstream NHS Wales impact multiplying the whole sum into the billions, and the patient-harm ledger continuing to accrue entries that cannot be reversed.
The Staff Cost — Also Not Counted
The figures above are pounds; the patient-harm ledger sits beside them. There is a third ledger: the cost to DHCW’s own staff of the financial strategy producing all of the above.
Working days lost to sickness rose from 8,684 in 2021-22 to 15,846 in 2024-25 — an 82% increase across three years, against headcount growth of approximately 30%. Long-term sickness rose 59%. The Annual Report 2024-25 records stress and anxiety as the leading cause. In the same window, the staff survey burnout rate moved from 65% (July 2024) to 68.9% (July 2025); the year-on-year increase was stripped from the published board minutes, as the original 65% figure had been twelve months earlier.
The mechanism is documented. Vacancy savings — the deliberate practice of holding posts unfilled to meet annual financial targets — have been built into DHCW’s financial plans every year since founding. At the 29 September 2022 board, the Chair, Simon Jones, warned in plain terms: “making recurrent savings through non-recurrent vacancies… is something I’ve got the scars on my back about… you just heap misery on misery every year when you do that.” The warning was completely erased from the published minutes. The strategy continued. By Q1 of Year 4, 84% of the in-year savings target had been delivered through unfilled posts. The downstream effect, three years on, is the sickness ledger.
Every credible body of research on high-performing digital delivery — Amy Edmondson, Google’s Project Aristotle, the DORA State of DevOps studies — identifies psychological safety and a culture of trust as the structural prerequisite. The DHCW record documents the inverse: bullying, suppression of dissent, retaliation against whistleblowers, and the use of vacancy and overtime as financial instruments. The Compassionate Leadership Pledge approved in fifteen seconds at the same board meeting where the 65% figure was reported was cited as a survey “strength” twelve months later — when burnout had risen to 68.9%. The label is the public-facing answer; the financial strategy producing the harm continues underneath.
This ledger does not translate directly into the £3-10 billion downstream NHS Wales figure above — staff sickness already shows up in the headcount-versus-output paradox the brief documents. But it is the human cost of the financial strategy, and like patient harm it cannot be undone by future reform. Every additional month of the status quo accrues entries.
The Cost of Trust That Cannot Be Bought Back
Even successful reform carries a cost the figures above do not show. Trust rebuilds on a 2-5 year lag behind demonstrated delivery — the credibility death spiral is a stock that must be replenished before health boards engage with national digital programmes again, and stocks fill slowly. The longer DHCW remains in its current state, the deeper the credibility deficit that has to be repaid. Health-board reluctance to adopt national systems, clinician disengagement from digital tooling, the loss of an entire generation of technical staff who learned that expertise did not matter — these are themselves costs of having allowed the spiral to deepen. They appear in no DHCW budget line. They appear in every clinical interaction across NHS Wales.